Company Overview - SiTime (SITM) currently holds a Momentum Style Score of B, indicating a positive momentum characteristic [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] Price Performance - Over the past week, SiTime shares have increased by 20.33%, significantly outperforming the Zacks Electronics - Miscellaneous Products industry, which rose by 1.48% [5] - The monthly price change for SiTime is 21.15%, compared to the industry's 3.06% [5] - In the last quarter, SiTime shares have risen by 38.3%, and over the past year, they have increased by 67.71%, while the S&P 500 has only moved 8.73% and 17.21% respectively [6] Trading Volume - SiTime's average 20-day trading volume is 373,288 shares, which is a useful indicator of market interest and can signal bullish or bearish trends [7] Earnings Estimates - In the past two months, three earnings estimates for SiTime have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $1.60 to $2.22 [9] - For the next fiscal year, three estimates have also moved upwards without any downward revisions [9] Conclusion - SiTime is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a strong candidate for investors seeking short-term gains [11]

Market Overview - The U.S. equity markets have experienced a downturn recently, primarily due to a pullback in blue-chip tech stocks, which has negatively impacted the overall market [1] - The 10-year Treasury yield has increased to 4.2%, influenced by solid economic data, including a revision of second-quarter GDP growth from 3.3% to 3.8% [1][2] - Weekly jobless claims decreased to 218,000 from 232,000, contrasting with expectations of 235,000 claims, indicating a robust job market [1][2] Federal Reserve and Interest Rates - The strong job market and revised GDP estimates have raised concerns about the Federal Reserve's potential interest rate cuts, following a recent reduction of 25 basis points to a range of 4.00%-4.25% [2] - Investors are awaiting the personal consumption expenditures price index reports for August for further insights into the Fed's rate cut policy [2] Momentum Investing Strategy - Momentum investing is highlighted as a strategy to capitalize on current trends, based on the principle of "buying high and selling higher" [3] - This strategy aims to profit from the tendency to extrapolate current trends into the future before mean reversion occurs [3] Screening Parameters for Momentum Stocks - The screening process identifies stocks with the best percentage price change over the last 52 weeks, selecting the top 50 performers [5] - From these, the bottom 10 performers over the past week are chosen to identify those experiencing short-term pullbacks [6] - Stocks with a Zacks Rank 1 (Strong Buy) and a Momentum Style Score of B or better are prioritized, indicating a higher probability of success [7] Selected Stocks - Wolverine World Wide, Inc. has seen a 62.5% increase over the past year but experienced an 8.2% decline last week, holding a Momentum Score of B [9][11] - Carpenter Technology Corporation has risen 48.9% in the past year but fell 5.8% last week, also with a Momentum Score of B [12][13] - Astera Labs, Inc. has surged 266.5% over the past year but dropped 20.3% last week, backed by a Momentum Score of A [14][15]

Core Viewpoint - Momentum investing focuses on "buying high and selling higher," contrasting with traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investing can be risky as stocks may lose momentum if future growth does not justify high valuations [1] - Identifying the right entry point for fast-moving stocks is challenging, and traditional momentum parameters may not always be reliable [1] Group 2: Bargain Stocks and Screening - Investing in bargain stocks with recent price momentum can be a safer strategy [2] - The Zacks Momentum Style Score is useful for identifying strong momentum stocks, while the 'Fast-Paced Momentum at a Bargain' screen helps find attractively priced fast-moving stocks [2] Group 3: Constellium (CSTM) Analysis - Constellium (CSTM) has shown a four-week price change of 3%, indicating growing investor interest [3] - CSTM gained 2.8% over the past 12 weeks, with a beta of 1.7, suggesting it moves 70% more than the market [4] - CSTM has a Momentum Score of B, indicating a favorable time to invest [5] - The stock has a Zacks Rank 2 (Buy) due to upward revisions in earnings estimates, which attract more investors [6] - CSTM is trading at a Price-to-Sales ratio of 0.27, meaning investors pay 27 cents for each dollar of sales, indicating a reasonable valuation [6] Group 4: Additional Investment Opportunities - Besides CSTM, there are other stocks that meet the 'Fast-Paced Momentum at a Bargain' criteria, suggesting further investment opportunities [7] - Zacks offers over 45 Premium Screens tailored to different investing styles to help identify winning stock picks [8]

Core Viewpoint - Supernus Pharmaceuticals (SUPN) is identified as a strong momentum stock with a Zacks Rank of 1 (Strong Buy) and a Momentum Style Score of B, indicating potential for significant near-term gains [4][12]. Company Performance - SUPN shares have increased by 1.28% over the past week, outperforming the Zacks Medical - Generic Drugs industry, which rose by 0.97% during the same period [6]. - Over the last month, SUPN's stock price has risen by 4.5%, compared to the industry's 1.4% [6]. - In the last quarter, SUPN shares have surged by 46.87%, and over the past year, they have gained 57.31%, significantly outperforming the S&P 500, which increased by 9.31% and 17.01% respectively [7]. Trading Volume - The average 20-day trading volume for SUPN is 645,479 shares, which serves as a bullish indicator when combined with rising stock prices [8]. Earnings Outlook - In the past two months, two earnings estimates for SUPN have been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from $1.50 to $2.18 [10]. - For the next fiscal year, two estimates have also moved upwards with no downward revisions [10].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: HF Sinclair (DINO) - HF Sinclair currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3] Price Performance - Over the past week, HF Sinclair shares increased by 2.76%, while the Zacks Oil and Gas - Refining and Marketing industry rose by 2.87% [5] - In a longer timeframe, the monthly price change for DINO is 6.1%, outperforming the industry's 5.38% [5] - Over the last quarter, HF Sinclair shares have risen by 22.15%, and by 18.45% over the past year, compared to the S&P 500's increases of 9.31% and 17.01%, respectively [6] Trading Volume - The average 20-day trading volume for DINO is 2,277,526 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, four earnings estimates for DINO have been revised upwards, while none have been lowered, boosting the consensus estimate from $2.54 to $3.57 [9] - For the next fiscal year, four estimates have increased, with one downward revision noted [9] Conclusion - Given the strong momentum indicators and positive earnings outlook, HF Sinclair is positioned as a solid momentum pick with a Momentum Score of A and a Zacks Rank of 2 (Buy) [11]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Arcutis Biotherapeutics, Inc. (ARQT) - ARQT currently holds a Momentum Style Score of B, indicating potential as a solid momentum pick [3][12] - The company has a Zacks Rank of 2 (Buy), which is associated with a strong track record of outperformance [4][12] Performance Metrics - Over the past week, ARQT shares increased by 0.52%, while the Zacks Medical - Biomedical and Genetics industry remained flat [6] - In a longer timeframe, ARQT's monthly price change is 10.54%, significantly outperforming the industry's 0.92% [6] - Over the last quarter, ARQT shares rose by 25.73%, and over the past year, they increased by 90.11%, compared to the S&P 500's gains of 9.31% and 17.01%, respectively [7] Trading Volume - ARQT's average 20-day trading volume is 1,603,419 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, two earnings estimates for ARQT have been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from -$0.55 to -$0.46 [10] - For the next fiscal year, two estimates have also moved upwards with no downward revisions [10]

Core Viewpoint - Prenetics Global Limited (PRE) is identified as a strong momentum stock with a Momentum Style Score of A and a Zacks Rank of 2 (Buy), indicating potential for significant near-term gains [3][4][12]. Company Performance - Over the past week, PRE shares have increased by 19.11%, while the Zacks Medical - Biomedical and Genetics industry remained flat during the same period [6]. - In a longer timeframe, PRE's monthly price change is 85.14%, significantly outperforming the industry's 0.92% [6]. - Over the past quarter, PRE shares have risen by 73.2%, and over the last year, they have surged by 249.49%, compared to the S&P 500's increases of 9.31% and 17.01%, respectively [7]. Trading Volume - The average 20-day trading volume for PRE is 118,382 shares, which serves as a bullish indicator when combined with rising stock prices [8]. Earnings Outlook - In the last two months, one earnings estimate for PRE has been revised upward, while none have been revised downward, leading to an increase in the consensus estimate from -$2.71 to -$2.56 [10]. - For the next fiscal year, one estimate has also moved upwards with no downward revisions noted [10].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Analysis: Lyft (LYFT) - Lyft currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy), indicating strong potential for outperformance [3][4] - Over the past week, Lyft shares have increased by 21.27%, while the Zacks Internet - Services industry remained flat [6] - In a longer timeframe, Lyft's shares have risen by 35.75% over the past month, significantly outperforming the industry's 1.73% [6] - Over the last quarter, Lyft shares have increased by 40.42%, and by 65.24% over the past year, compared to the S&P 500's gains of 9.31% and 17.01%, respectively [7] - The average 20-day trading volume for Lyft is 25,890,020 shares, which is a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, 6 earnings estimates for Lyft have been revised upwards, increasing the consensus estimate from $1.10 to $1.18 [10] - For the next fiscal year, 4 estimates have moved up while 1 has been revised down [10] - These positive earnings revisions contribute to Lyft's strong Momentum Score and Zacks Rank [9][11]

Core Viewpoint - The article discusses the author's investment philosophy, which incorporates various strategies including fundamental, technical, and momentum investing, emphasizing the importance of a diversified approach to capital management [1]. Group 1: Investment Philosophy - The author believes in the merits of different investment approaches, such as fundamental investing, technical investing, and momentum investing [1]. - The investment process has been refined over the years by leveraging the positive aspects of each approach [1]. Group 2: Purpose of Writing - The article serves as a platform for tracking the performance of the author's investment ideas and connecting with like-minded investors [1].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1][2]. Company Overview: Life360 (LIF) - Life360 currently holds a Momentum Style Score of A, indicating strong momentum characteristics [3]. - The company has a Zacks Rank of 2 (Buy), suggesting a favorable outlook based on historical performance metrics [4]. Price Performance - Over the past week, Life360 shares increased by 2.67%, outperforming the Zacks Security and Safety Services industry, which rose by 1.34% [6]. - In a longer timeframe, Life360's shares have risen by 57.66% over the past quarter and 156.12% over the last year, significantly outperforming the S&P 500's gains of 10.87% and 17.74%, respectively [7]. Trading Volume - Life360's average 20-day trading volume is 1,133,771 shares, which serves as a bullish indicator when combined with rising stock prices [8]. Earnings Outlook - In the last two months, two earnings estimates for Life360 have been revised upwards, with the consensus estimate increasing from $0.24 to $0.31 [10]. - For the next fiscal year, two estimates have also moved higher, with no downward revisions noted [10]. Conclusion - Considering the positive price trends, strong earnings outlook, and favorable momentum indicators, Life360 is positioned as a 2 (Buy) stock with a Momentum Score of A, making it a potential candidate for near-term investment [12].